Systemic Infusion of Expanded CD133+ Cells and Expanded CD133+ Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI
Myocardial infarction is a leading cause of death among all cardiovascular diseases. Cell therapies using a cell population enriched with endothelial progenitor cells (EPCs), expanded CD133+ cells, have promise as a therapeutic option for the treatment of ischemic areas after infarction. Recently, s...
Saved in:
Main Authors: | Addeli B. B. Angulski (Author), Luiz Guilherme A. Capriglione (Author), Fabiane Barchiki (Author), Paulo Brofman (Author), Marco A. Stimamiglio (Author), Alexandra C. Senegaglia (Author), Alejandro Correa (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanded CD133+ Cells from Human Umbilical Cord Blood Improved Heart Function in Rats after Severe Myocardial Infarction
by: Alejandro Correa, et al.
Published: (2018) -
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
by: Borger Darrell R, et al.
Published: (2010) -
Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease
by: Xiaoping Zhang, et al.
Published: (2016) -
PHYSIOLOGICAL ROLE OF BONE MARROW ADULT STEM CELL CD133+
by: J. IRGASHEVA, et al.
Published: (2017) -
DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma
by: Raynoo Thanan, et al.
Published: (2016)